Cases

Search for a case

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Cases

December 21, 2022

Brunswick Bancorp Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Brunswick Bancorp (“Brunswick” or the “Company”)(OTC: BRBW) in connection with the proposed acquisition of the Company by Mid Penn Bancorp, Inc. (“Mid Penn”) (NASDAQ: MPB). Under the merger agreement, Brunswick shareholders will have the option to elect to receive either 0.598 shares of Mid Penn common stock, representing implied per-share consideration of $9.84 based upon Mid Penn’s December 20, 2022 closing price of $16.45, or $18.00 in cash for each common share of Brunswick they own, subject to proration to ensure that, in the aggregate, 50% of the transaction consideration will be paid in the form of Mid Penn common stock.

Join Case →

December 21, 2022

Mid Penn Bancorp, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Mid Penn Bancorp, Inc. (“Mid Penn” or the “Company”) (NASDAQ: MPB), in connection with its acquisition of Brunswick Bancorp (OTC: BRBW) for approximately $53.9 million in a combination of cash and Mid Penn stock.

Join Case →

December 19, 2022

Aerojet Rocketdyne Holdings, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Aerojet Rocketdyne Holdings, Inc. (“Aerojet” or the “Company”) (NYSE: AJRD), in connection with the proposed acquisition of the Company by L3Harris Technologies, Inc. (NYSE: LHX). Under the terms of the merger agreement, the Company’s shareholders will receive $58.00 in cash for each share of Aerojet common stock owned.

Join Case →

December 19, 2022

Trean Insurance Group, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Trean Insurance Group, Inc. (“Trean” or the “Company”) (NASDAQ: TIG), in connection with the proposed acquisition of the Company by affiliates of Altaris, LLC. Under the terms of the merger agreement, the Company’s shareholders will receive $6.15 in cash for each share of Trean common stock owned.

Join Case →

December 16, 2022

The Community Financial Corporation Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of The Community Financial Corporation (“TCFC” or the “Company”) (NASDAQ: TCFC) in connection with the proposed merger of the Company with Shore Bancshares, Inc. (“Shore”) (NASDAQ: SHBI). Under the merger agreement, the Company’s shareholders will receive 2.3287 shares of Shore common stock for each TCFC share, representing implied per-share consideration of $40.17 based upon Shore’s December 15, 2022 closing price of $17.25.

Join Case →

December 16, 2022

Shore Bancshares, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Shore Bancshares, Inc. (“Shore” or the “Company”) (NASDAQ: SHBI), in connection with the proposed merger of the Company with The Community Financial Corporation (“TCFC”) (NASDAQ: TCFC).

Join Case →

December 14, 2022

Vallon Pharmaceuticals, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Vallon Pharmaceuticals, Inc. (“Vallon” or the “Company”) (NASDAQ: VLON), in connection with the proposed merger of the Company with GRI Bio, Inc. (“GRI Bio”). Under the merger agreement, Vallon will acquire 100% of the outstanding equity interests of GRI Bio, by means of reverse triangular merger of a wholly owned subsidiary of Vallon with and into GRI Bio, with GRI Bio surviving as a wholly owned subsidiary of Vallon.

Join Case →

December 14, 2022

Malvern Bancorp, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Malvern Bancorp, Inc. (“Malvern” or the “Company”) (NASDAQ: MLVF), in connection with the proposed acquisition of the Company by First Bank (“First Bank”) (NASDAQ: FRBA). Under the merger agreement, the Company’s shareholders will receive 0.7733 shares of First Bank common stock, plus $7.80 in cash for each outstanding Malvern share, representing implied per-share consideration of $19.64 based upon First Bank’s December 13,2022 closing price of $15.31.

Join Case →

December 13, 2022

Sesen Bio, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Sesen Bio, Inc. (“Sesen” or the “Company”) (NASDAQ:SESN), in connection with the proposed merger of the Company with Carisma Therapeutics Inc. (“Carisma”). Under the merger agreement, Carisma shareholders will receive newly issued shares of Sesen common stock pursuant to an exchange ratio formula set forth in the merger agreement. Immediately priort o the closing of the proposed merger, the Company’s shareholders will be issued a contingent value right (“CVR”) for each outstanding share of Sesen common stock held.

Join Case →

We will fight for you and have your back no matter what. Join the tens of thousands of people we’ve helped.

Cases

Search for a case

Cases

Brunswick Bancorp Investigation

Mid Penn Bancorp, Inc. Investigation

Aerojet Rocketdyne Holdings, Inc. Investigation

Trean Insurance Group, Inc. Investigation

The Community Financial Corporation Investigation

Shore Bancshares, Inc. Investigation

Vallon Pharmaceuticals, Inc. Investigation

Malvern Bancorp, Inc. Investigation

Sesen Bio, Inc. Investigation

Where to find us?

new york

california

georgia

NEW JERSEY